Early Switch to Oral Anticoagulation in Patients with Acute Intermediate-Risk Pulmonary Embolism (PEITHO-2): a Multinational, Multicentre, Single-Arm, Phase 4 Trial Frederikus A. Klok , Gerrit Toenges , Anna C. Mavromanoli , Stefano Barco , Walter Ageno , Helene Bouvaist , Marianne Brodmann , Claudio Cuccia , Francis Couturaud , Claudia Dellas , Konstantinos Dimopoulos , Daniel Duerschmied , Klaus Empen , Pompilio Faggiano , Emile Ferrari , Nazzareno Galie , Marcello Galvani , Alexandre Ghuysen , George Giannakoulas , Menno Huisman , David Jimenez , Matija Kozak , Irene Marthe Lang , Mareike Lankeit , Nicolas Meneveau , Thomas Munzel , Massimiliano Palazzini , Antoniu Octavian Petris , Giancarlo Piovaccari , Aldo Salvi , Sebastian Schellong , Kai-Helge Schmidt , Franck Verschuren , Irene Schmidtmann , Guy Meyer , Stavros Konstantinides The Lancet Haematology（2021）
Key words
Infarction Treatment, Anticoagulant Therapy, Treatment
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
